Abstract
Targeting CD38high Acute Myeloid Leukaemia with “Affinity Optimized” Chimeric Antigen Receptor and Membrane Bound TRAIL Expressing Natural Killer Cells
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have